| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(99)00318-6 |
| P698 | PubMed publication ID | 10520779 |
| P2093 | author name string | H Ogawa | |
| H Yasue | |||
| K Kugiyama | |||
| M Yoshimura | |||
| H Soejima | |||
| S Nakamura | |||
| K Nishiyama | |||
| S Miyamoto | |||
| I Tsuji | |||
| K Misumi | |||
| K Takazoe | |||
| K Kaikita | |||
| P2860 | cites work | Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions | Q30450846 |
| cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI). | Q33231056 | ||
| Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation | Q33890331 | ||
| Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis | Q33895278 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 | ||
| Increased monocyte tissue factor expression in coronary disease | Q36815173 | ||
| Properties of the novel proinflammatory supergene "intercrine" cytokine family. | Q37357898 | ||
| Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions | Q43472007 | ||
| Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI) | Q44806369 | ||
| Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina | Q47988395 | ||
| Comparison of plasma tissue factor levels in unstable and stable angina pectoris. | Q50908719 | ||
| Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. | Q52523874 | ||
| Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. | Q52531825 | ||
| Some statistical methods useful in circulation research. | Q52759617 | ||
| Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients | Q68599026 | ||
| Factor VII and extrinsic pathway inhibitor in acute coronary disease | Q69743039 | ||
| Measurement of the free form of TFPI antigen in hyperlipidemia. Relationship between free and endothelial cell-associated forms of TFPI | Q71101455 | ||
| Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction | Q71403727 | ||
| Identification of active tissue factor in human coronary atheroma | Q71571184 | ||
| Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor | Q71684060 | ||
| Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture | Q72092927 | ||
| Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes | Q72425667 | ||
| Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction | Q73088379 | ||
| Tissue-factor antigen and activity in human coronary atherosclerotic plaques | Q73164621 | ||
| Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis | Q73267274 | ||
| Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction | Q73304525 | ||
| Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators | Q73558450 | ||
| Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs | Q73558502 | ||
| Increased plasma tissue factor levels in acute myocardial infarction | Q73739624 | ||
| Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells | Q73804432 | ||
| Tissue factor expression on macrophages in coronary plaques in patients with unstable angina | Q73832979 | ||
| Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes | Q77391990 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 983-988 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction | |
| P478 | volume | 34 |
| Q28165999 | Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating Inflammation |
| Q28251955 | Angiotensin antagonism in coronary artery disease: results after coronary revascularisation |
| Q36832522 | Antiphospholipid antibody effects on monocytes |
| Q43633275 | Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction |
| Q24799394 | Cytokines as new treatment targets in chronic heart failure |
| Q57417723 | Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting |
| Q37563372 | Effect of hormone replacement therapy on inflammatory biomarkers. |
| Q43787126 | Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels |
| Q35636401 | Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implications |
| Q44597999 | HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells |
| Q58585456 | Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications |
| Q35099157 | Inflammation and angiotensin II. |
| Q47437758 | Inflammation as a therapeutic target: a unique role for abciximab |
| Q33348014 | Intravenous vasodilator therapy in congestive heart failure |
| Q45222201 | Leukocytosis and adverse hospital outcomes after acute myocardial infarction |
| Q40446691 | Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease. |
| Q79288146 | New approaches to prevention of thrombosis in the antiphospholipid syndrome: Hopes, trials, and tribulations |
| Q36592534 | Novel hydroxybutyl chitosan nanoparticles for siRNA delivery targeting tissue factor inhibits proliferation and induces apoptosis in human vascular smooth muscle cells |
| Q35736381 | Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance |
| Q79298703 | Polymorphism of the Monocyte Chemoattractant Protein (MCP-1) Gene Is Associated with the Plasma Level of MCP-1 But Not with Carotid Intima-Media Thickness |
| Q34522536 | Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease |
| Q35027759 | Regulation of chemokine expression in atherosclerosis |
| Q44016826 | Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes |
| Q64937621 | Role of Macrophages in Cardioprotection. |
| Q38106962 | Role of monocyte chemoattractant protein-1 in myocardial infarction |
| Q46865405 | Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression |
| Q38034092 | Role of tissue factor in atherothrombosis |
| Q34060768 | The multiple actions of angiotensin II in atherosclerosis |
| Q36442587 | The renin-angiotensin system and atherosclerosis |
| Q37158159 | The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies |
| Q42437067 | Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin |
Search more.